Regarding symptoms that appear to be aftereffects such as sore throat and malaise that continue after being infected with the new coronavirus, Shionogi & Co., Ltd. has conducted clinical trials and found that those who took the oral drug "Zokoba" when infected had symptoms after half a year. announced that the risk of coming out has dropped by about half.
Zokova is said to shorten the time it takes for symptoms such as fever to improve by one day, and was urgently approved for administration to people aged 12 and over in November last year as the first oral drug for the new corona that can be used by people with a low risk of becoming severe. I was.
On the 22nd of Japan time, Shionogi & Co. announced the results of the final stage of the clinical trial presented at the conference on infectious diseases held in the United States.
According to it, out of the more than 1,800 people who participated in the trial, there was a certain degree of symptoms after being infected with the new corona, and 14 symptoms such as coughing, sore throat, malaise, and taste disorder after half a year in patients who took Zokova. It was 14.5% who sued one of them.
On the other hand, 26.3% of those who took the fake medicine complained of symptoms, and the company said that those who took Zokova had a 45% lower risk of developing symptoms that could be seen as sequelae.
In addition, the risk of neurological symptoms such as decreased concentration and thinking ability, forgetfulness and insomnia decreased by 33%.
Shionogi says, ``We will continue to follow up until one year later,'' and if another clinical trial yields good results, we aim to apply for additional approval as a drug that can be used to prevent sequelae.